Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy

Interactive Cardiovascular and Thoracic Surgery

Volumn 16, Issue 2, 2013, Pages 166-172

  Saisho, Shinsuke ^a   Yasuda, Koichiro ^a   Maeda, Ai ^a   Yukawa, Takuro ^a   Okita, Riki ^a   Hirami, Yuji ^a   Shimizu, Katsuhiko ^a   Nakata, Masao ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Adjuvant chemotherapy; Non small cell lung cancer; Post recurrence survival

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; MOLECULAR MARKER; PLATINUM DERIVATIVE; UFT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE CONTROL; FEMALE; HUMAN; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PLEOMORPHIC ADENOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEGMENTECTOMY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WEDGE RESECTION; WILD TYPE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872721743     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs450     Document Type: Article

References (25)

1. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study. Lung Cancer 2005;50:227-34. (Pubitemid 41427898)
2. Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M et al. A Japanese lung cancer registry study-prognosis of 13, 010 resected lung cancers. J Thorac Oncol 2008;3:46-52.
3. Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M et al. Japanese lung cancer registry study of 11, 663 surgical cases in 2004-demographic and prognosis change over decade. J Thorac Oncol 2011;6: 1229-35.
4. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-60. (Pubitemid 38101630)
5. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C et al. ; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR. 10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97. (Pubitemid 41007845)
6. Douillard JY, Rosell R, Lena MD, Carpagnano F, Ramlau R, Gonzales-Larriba JL et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 2006;7:719-27. (Pubitemid 44283661)
7. Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007;25:313-8. (Pubitemid 350003020)
8. Kunitoh H, Kato H, Tsuboi M, Shibata T, Asamura H, Ichonose Y et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group Trial 9806. J Clin Oncol 2008;26:644-9. (Pubitemid 351264361)
9. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A et al. Randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994;330:153-8. (Pubitemid 24026882)
10. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994;86:673-80.
11. van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99:442-50. (Pubitemid 47073567)
12. Thomas M, Rube C, Hoffknecht P, Macha HN, Freitag L, Linder A et al. ; German Lung Cancer Cooperative Group. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: A randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 2008; 9:636-48.
13. Al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 1997;12: 380-4. (Pubitemid 27397975)
14. Martin J, Ginsberg RJ, Venkatraman ES, Bains MS, Downey RJ, Korst RJ et al. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol 2002;20:1989-95. (Pubitemid 34408788)
15. Ichinose Y, Hara N, Ohta M, Motohiro A, Kuda T, Aso H. Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival. J Surg Oncol 1991;46:15-20.
16. Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K et al. Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection. J Thorac Cardiovasc Surg 1994;108:158-61. (Pubitemid 24224272)
17. Yoshino I, Yohena T, Kitajima M, Ushijima C, Nishioka K, Ichinose Y et al. Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs. Ann Thorac Cardiovasc Surg 2001;7:204-9.
18. Williams BA, Sugimura H, Endo C, Nichols FC, Cassivi SD, Allen MS et al. Predicting postrecurrence survival among completely resected non-small-cell lung cancer patients. Ann Thorac Surg 2006;81:1021-7. (Pubitemid 43247679)
19. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C et al. Survival after recurrent non-small-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 2007;83:409-18. (Pubitemid 46135441)
20. Travis WD, Colby TB, Corrin B, Shimosato Y, Brambilla E. Histological typing of tumors of lung and pleura. In: Sobin LH (ed). World Health Organization International Classification of Tumours. 3rd edn. New York: Springer-Verlag, 1999, 21-47.
21. Sobin L, Gospodarowicz M, Witterkind C. International Union Against Cancer: TNM Classification of Malignant Tumors. 7th edn. New York: John Wiley & Sons, Inc. ; 2009.
22. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1. 1). Eur J Cancer 2009;45:228-47.
23. Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR et al. ; National Comprehensive Cancer Network (NCCN). Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006;4:548-82. (Pubitemid 44265463)
24. Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H et al. ; Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713-21. (Pubitemid 38501140)
25. Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafururacil in non-small-cell lung cancer. J Clin Oncol 2005;23:4999-5001.